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Abstract A complementary DNA clone predicted to encode a 
novel transporter was isolated from rat brain and the localization 
of its mRNA was examined. The cDNA, designated rB21a, pre- 
dicts a protein with 12 putative transmembrane domains that 
exhibits significant sequence homology with neurotransmitter 
transporters. Expression studies have not yet identified the en- 
dogenous nbstrate for this transporter, but the presence of rB21 a 
mRNA within the leptomeninges of the brain suggests the trans- 
porter may regulate CSF levels of its substrate. The cloning of 
rB21 a provides the means to determine its physiological functions 
and the potential to design novel, transporter-based therapeutic 
agents for neurological and psychiatric disorders. 
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1. Introduction 
Transporters throughout the body control the solute compo- 
sition of the CSF, urine, plasma, and other extracellular fluids. 
In the brain, neurotransmitter transporters subserve specialized 
functions related to the modulation of synaptic transmission. 
The cloning of genes encoding neurotransmitter transporters is 
facilitating the elucidation of the role of transport proteins in 
nervous system function. The availability of cloned trans- 
porters provides the opportunity todefine the pharmacological 
profiles of specific gene products, map their patterns of distri- 
bution, and make correlations with in vivo observations to 
better understand their biological functions. 
Since the description of the primary structure of the first 
neurotransmitter ransporter, the GABA transporter GAT-1 
[1], at least 10 additional transporters with related sequences 
have been cloned (see [2] for review), defining a new gene 
family. Members of this family typically exhibit from ~40% to 
-70% overall amino acid identity with each other, and share a 
number of structural and functional features, including 12 pre- 
dicted transmembrane domains, potential sites for glycosyla- 
tion in extracellular domains, and dependence on sodium for 
transport activity. Transporters in this family include those for 
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norepinephrine [3], serotonin [4,5], dopamine [6,7], glycine 
[8 12], GABA [1,13-15], betaine [16,17], taurine/~-alanine 
[18-20]), L-proline [21], and creatine [22]. All of these trans- 
porters are found in the brain and their substrates typically 
serve as neuroregulators, o moregulators, or both, reinforcing 
the concept hat molecules with similar structures often have 
similar functions. 
Several additional transporters have been cloned that exhibit 
significant amino acid identity with the neurotransmitter trans- 
porters, but whose endogenous substrates have not yet been 
identified [23-25]. We describe here the cloning and localization 
of a novel 'orphan' transporter f om rat brain, designated 
rB21 a, whose structural homology with neurotransmitter trans- 
porters indicates it is related to this gene family. Its presence 
in restricted brain areas and cell types further suggests that its 
endogenous substrate may be neuroactive. As a novel trans- 
porter homologous to neurotransmitter ransporters, rB21a 
may be useful as a target for the development of therapeutic 
agents for neurological nd psychiatric disorders. The cloning 
of rB21a provides the basis for exploring its functions in the 
nervous ystem and elsewhere. 
2. Experimental 
2.1. Screening of the rat brain cDNA library and sequencing 
A rat brain cDNA library in the Lambda ZAP II vector (Stratagene, 
La Jolla, CA) was screened at low stringency as previously described 
[8] using probes representing the coding region of the rat GAT-1 GABA 
transporter cDNA [1]. Lambda phage hybridizing to the probe were 
plaque purified and screened with the same probe mixture at high 
stringency to eliminate GAT-I cDNAs, rB21a clones were converted 
to phagemids by in vivo excision with fl helper phage. Nucleotide 
sequences of cDNAs in pBluescript were analyzed on both strands by 
the Sanger dideoxy nucleotide chain-termination method [26] using 
Sequenase (U.S. Biochemical Corp., Cleveland, OH). 
2.2. Expression and uptake assays in COS-7 cells" 
Two cDNA clones were identified which collectively span the entire 
coding region of the rB21a transporter gene, including 274 base pairs 
of 5' untranslated sequence and 902 base pairs of 3' untranslated se- 
quence. The two clones were ligated at their internal BamHI sites to 
create a full-length 3.0 kb cDNA and subcloned into the eukaryotic 
expression vector pcEXV-3 [27] for pharmacological haracterization. 
Transient transfection fCOS-7 cells with rB2 la was carried out using 
DEAE-dextran with DMSO according to the method of Lopata et al. 
[28] with minor modifications. Transport of putative substrates was 
measured inCOS-7 cells two days after transfection aspreviously de- 
scribed [13] using 50 nM [3H]substrate (6-90 Ci/mmol; New England 
Nuclear, Boston, MA). Non-specific uptake was defined in parallel 
wells with 1 mM unlabeled substrate. 
Abbreviations: GABA, y-aminobutyric a id; CSF, cerebrospinal fluid; 
TM, transmembrane domain; RT-PCR, reverse transcriptase-polym- 
erase chain reaction. 
2.3. Preparation of cell cultures 
Primary cultures of neurons, astrocytes, and fibroblasts were pre- 
pared from El9 embryonic rats. Briefly, the brains were removed, 
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dissected free of meninges, and trypsinized. Cells were dissociated me- 
chanically by passage through a Pasteur pipette, and resuspended in
DMEM containing 10% fetal bovine serum and antibiotics. The cells 
were added to tissue culture dishes that had been previously coated with 
10/IM poly-D-lysine. Type 1 and O-2A/Type 2 astrocyte cultures were 
prepared as described elsewhere [29]. For neurons, a plating density of 
15 × 10 6 cells per 100 mm dish was employed; the medium was supple- 
mented with insulin. Cytosine arabinoside was added to a final concen- 
tration of 10 ,uM on day 2 or 3 to inhibit the proliferation of non- 
neuronal cells; the neurons were harvested 1 week after plating. To 
obtain meningeal cells, the meninges were trypsinized and mechanically 
dissociated as described above. The cells recovered from a single em- 
bryo were plated into a 100 mm dish, grown to confluence, and pas- 
saged 1 2 times prior to harvesting. Fibroblasts from skin were pre- 
pared as described for meningeal cells. 
2.4. Northern blot analysis 
Total cellular RNA was isolated from rat tissues and cells using 
guanidine isothiocyanate and collected by centrifugation through ce- 
sium chloride [30], as modified from the method of Chirgwin et al. [31]. 
Poly(A) ÷ RNAs were purchased from Clontech (Palo Alto, CA). Dena- 
tured RNA samples (5 25 /lg) were separated by electrophoresis in 
1.0% agarose gels containing 2.7% formaldehyde. RNAs were trans- 
ferred to GeneScreen Plus membranes (Dupont-NEN, Boston, MA) by 
overnight capillary blotting in 10 x SSC. Northern blots were rinsed 
and then baked for 2 h at 80°C under vacuum. Prehybridization was 
for 1 2 h at 42°C in a solution containing 50% formamide, 1M sodium 
chloride, 10% dextran sulfate and 1.0% SDS. Blots were hybridized 
overnight at 42°C with 32p-labeled rB21a cDNA (randomly primed) in 
prehybridization mixture containing 100/~g/ml sonicated salmon sperm 
DNA. The blots were washed successively in 2 x SSC/2% SDS, 1 x 
SSC/2% SDS, and 0.2 x SSC/2% SDS at 65°C, then exposed to Kodak 
XAR-5 film with one intensifying screen at -80°C for up to three 
weeks. After hybridization with rB21a, blots were routinely reprobed 
with IB15 [32] in order to confirm that equal amounts of RNA were 
present in each lane. 
2.5. In situ hybridization 
Male Sprague Dawley rats (150 250 g) were decapitated and their 
brains and peripheral tissues were rapidly removed and frozen by im- 
mersion in isopentane on dry ice. Tissues were sectioned at 11/lm on 
a cryostat, thaw-mounted onto poly-h-lysine-coated sli es, and stored 
at -20°C until use. Pairs of antisense and sense oligonucleotides de- 
signed to the 7/8 loop and the 3'-untranslated region were synthesized 
on a Cyclone Plus DNA Synthesizer (Milligen/Bioresearch). The se- 
quences of the oligonucleotides (45-mers) were: 
Sense, 7/8 loop: 5'-CTGGAGGAGGTGAAGGACTACCTGGCA- 
TCTACTTACCCAAACAAG 
Antisense, 7/8 loop: 5'-CTTGTTTGGGTAAGTAGATGCCAGG- 
TAGTCCTTCACCTCCTCCAG 
Sense, 3'UT: 5'-GTCACCTTTCTCTGAATCTAAGGTTCCTCA- 
CAGTGGGCCAGGACA 
Antisense, 3'UT: 5'-TGTCCTGGCCCACTGTGAGGAACCTTA- 
GATTCAGAGAAAGGTGAC 
Probes were T-end labeled with [35S]dATP (1,200 Ci/mmol, New 
England Nuclear, Boston, MA) to a specific activity of 109 dpm/#g 
using terminal deoxynucleotidyl transferase (Boehringer Mannheim, 
Indianapolis, IN). Hybridization buffer consisted of 50% formamide, 
4× SSC (1 x SSC = 0.15 M NaC1 and 0.015 M sodium citrate), l x 
Denhardt's olution (0.2% polyvinyl-pyrrolodine, 0.2% Ficoll, 0.2% 
bovine serum albumin), 50 mM dithiothreitol, 0.5 mg/ml yeast RNA, 
and 10% dextran sulfate. Radiolabeled probe in 100 Itl hybridization 
buffer was applied to each tissue section and hybridized overnight at 
50°C. Sections were washed for 2 × 30 min in 2 x SSC at room temper- 
ature, for 1 h in 1 × SSC at room temperature, for 1 h in 2 × SSC at 
50°C, and for 30 min in 0.1 × SSC at room temperature. Tissues were 
dehydrated in a series of graded alcohols, apposed to Kodak XAR-5 
film for two weeks, then dipped in Kodak NTB3 autoradiography 
emulsion diluted 1 : 1 with 0.2% glycerol. After four weeks, slides were 
developed and counterstained with hematoxylin and eosin, and the 
cellular distribution of the exposed silver grains was examined with a 
Zeiss Axioskop. Parallel tissues pretreated with 100 Hg/ml RNase A 
(37°C, 30 min) prior to hybridization showed no significant signal. Both 
pairs of oligonucleotides for rB21a (see above) showed identical pat- 
terns of hybridization. 
3. Results 
3.1. Cloning 
To clone novel neurotransmitter  transporters we screened a
rat brain cDNA library at low stringency with probes encoding 
the rat GABA transporter GAT-1 [1]. A clone was identified, 
rB21a, that hybridized at low but not at high stringency with 
the GABA transporter probes, indicating it was related but not 
identical to GAT-1. DNA sequence analysis revealed that the 
clone encoded a putative transporter with 53% nucleotide iden- 
tity to GAT-1. Searches of GenBank and EMBL data bases 
demonstrated that the nucleotide sequence of rB21a was novel 
and that the most closely related sequence was that of an or- 
phan transporter designated NTT4 [24]. 
rB21a, a full-length cDNA, contained a 3.0 kb sequence with 
an open reading frame of 1,848 base pairs which could encode 
a protein of 616 amino acids with a relative molecular mass of 
-67,000 Daltons (Fig. 1). The deduced amino acid sequence of 
rB21a exhibited significant homology (36-41% amino acid 
identity) with the neurotransmitter  transporter gene family 
(Table 1). Slightly higher amino acid identities were observed 
with the 'orphan'  transporters NTT4 [24] and v7 3-2 [23] 
(-43%), while unrelated transporters uch as the sodium/ 
glucose cotransporter [33] exhibited much lower identity (~ 17%). 
Hydropathy analyses of rB21a indicate the presence of twelve 
putative t ransmembrane domains (TMs); potential sites for 
Asn-l inked glycosylation are located in the predicted second 
and fourth extracellular loops based on the membrane topology 
proposed for GAT-1 [1]. Al ignment of rB21a with the GAT-2 
and glycine transporters (Fig. 2) reveals that despite regions of 
high amino acid sequence conservation, rB21a is predicted to 
have a significantly longer loop between TMs VII and VIII 
than previously cloned neurotransmitter  transporters. 
3.2. Pharmacology 
Sequence comparisons uggested that rB21a might encode a 
neurotransmitter  t ansporter. To explore this possibility, a 
cDNA containing the full coding region of the rB21a trans- 
porter was placed in a mammal ian expression vector (pcEXV- 
3), transfected into COS-7 cells, and screened for transport  of 
a variety of radiolabeled neurotransmitters and amino acids. 
COS-7 cells transiently transfected with rB21a (COS/rB21a) 
failed to accumulate the potential substrates to a greater extent 
than non-transfected control cells (Table 2). The substrates 
tested included inhibitory amino acid neurotransmitters, 
monoamine neurotransmitters, amino acids and substrates for 
amino acid transporters, and other related endogenous com- 
pounds. Thus, the rB21a cDNA does not appear to encode a 
transporter for commonly known classical neurotransmitters. 
3.3. Localization 
To gain insight into the potential function of the rB21a trans- 
porter, we carried out localization studies of the mRNA encod- 
ing the transporter. Northern blot analysis of poly(A) ÷ RNAs 
from various rat tissues revealed a 3.0 kb transcript in brain, 
kidney, and lung that hybridized at high stringency with rB21a 
(Fig. 3). In the kidney, an addit ional -2 .6  kb hybridizing tran- 
script was present which could represent either a related 
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GGCAGGGTGGGGCTCACCGCTCCCCACTTACCGGCCTCGCCCCTCTCGTGCGCGTTA TG AGA TTA GCA ATT AAA 18 
Net Arg Leu Ala lle Lys 6 
AGG CGG GCG AGC CGC GGC CAG AGA CCA GGC CCT GAC GAG AAG CGAGCG CGG GAC ATG GAG AAG GCA CGG CCT CAA 93 
Arg Arg ALe Set Arg GLy Gln Arg Pro GLy Pro Asp Glu Lys Arg ALe Arg Asp Net Glu Lys Ala Arg Pro Gln 31 
TGG GGC AAT CCG CTG CAG TTC GTT TTC GCC TGT ATC TCC TAC GCC GTG GGT TTG GGC FAT GTG TGG CGC TTC CCC 168 
Trp GLy Asn Pro Leu Gln Phe Vat Phe Ata Cys I re  Ser Tyr Ala Vat GIy Leu GLy Asn Vat Trp Arg Phe Pro 56 
TAC CTG TGC CAG ATG TAC GGC GGA GGG AGT TTC CTG GTC CCC TAC CTC ATC ATG CTC ATT GTG GAG GGG ATG CCA 243 
Tyr Leu Cys Gln Met Tyr GLy GLy GLy Ser Phe Leu Vat Pro Tyr Leu I le  Met Leu I le  Vat Glu GLy Met Pro 81 
CTC TTG TAG CTG GAG CTG GCT GTG GGG CAG CGC ATG CGG CAG GGC AGC ATT GGT GCC TGG AGG ACC ATC AGC CCC 318 
Leu Leu Tyr Leu Glu Leu Ala Vat GIy Gin Arg Met Arg Gln Gty Ser I l e  Gty Ala Trp Arg Thr l i e  Ser Pro 106 
TAC CTT AGT GGT GTC GGT GTT GCC AGT GTG GTG GTC TCC TTC TTC CTC TCC ATG TAC TAC FAT GTC ATC FAT GCC 393 
Tyr Leu Ser GLy Vat Gly VaL Ata Sen Va[ Vat Val Ser Phe Phe Leu Ser Net Tyr Tyr Asn Val I l e  Asn Ata 131 
TGG GGC TTC TGG TAC CTC TTC CAC TCC TTC CAG GAT CCC CTG CCG TGG TCT GTC TGC CCA CTG FAT AGT FAC CGC 468 
Trp Gty Phe Trp Tyr Leu Phe His Ser Phe Gln Asp Pro Leu Pro Trp Ser Vat Cys Pro Leu Asn Ser A~n Arg 156 
ACA GGC TAT GAT GAG GAG TGT GAG FAG GCT TCG TCG ACA CAG TAC TTC TGG TAC AGG AAAACA CTCFAC ATC TCA 543 
Thr Gty Tyr Asp Glu Gtu Cys Gtu Lys Ala Ser Ser Thr Gtn Tyr Phe Trp Tyr Arg Lys Thr Leu Asn I re  Ser 181 
CCG TCC ATC CAG GAG FAT GGA GGA GTG CAG TGG GAG CCA GCC CTG TGC CTC ACC CTG GCC TGG CTG ATG GTA TAT 618 
Pro Ser ILe Gtn Gtu Asn Gty Gty Vat Gln Trp Glu Pro Ata Leu Cys Leu Thr Leu Ata Trp Leu Net Vat Tyr 206 
CTG TGC ATC CTG AGA GGC ACC GAA TCT ACT GGC AAG GTG GTC TAC TTC ACC GCA TTG ATG CCT TAC TGT GTT CTT 69] 
Leu Cys I le  Leu Arg GLy Thr Gtu Ser Thr Gty Lys Vat Vat Tyr Phe Thr Ata Leu Net Pro Tyr Cys Vat Leu 231 
ATT ATC TAC TTG GTC CGT GGC CTC ACA CTC CAT GGA GCC ACC AAT GGC CTG ATG TAC ATG TTC ACA CCT FAG ATT 708 
I l e  I l e  Tyr Leu Val Arg GLy Leu Thr Leu His Gty Ata Thr Asn GIy Leu Net Tyr Met Phe Thr Pro Lys l i e  256 
GAG CAG CTA GCC FAC CCC FAG GCC TGG ATC FAT GCA GCC ACG CAG ATC TTC TTC TCA CTG GGC TTG GGT TTT GGC 843 
GLu Gln Leu Ala Asn Pro Lys Ala Trp I re  Asn Ata ALe Thr Gin I le  Phe Phe Set Leu Gty Leu GLy Phe Gly 281 
AGC CTG ATC GCT TTT GCC AGC TAC FAT GFA CCC TCC AAC GAC TGC CAGAAG CAT GCT GTC ATT GTG TCT GTC ATC 918 
Ser Leu I le  Ala Phe Ata Ser Tyr Ash Gtu Pro Ser Asn Asp Cys Gln Lys His Ala Vat I l e  Val Ser Vat I l e  306 
AAC AGC TCC ACC TCC ATA TTT GCC AGC ATT GTC ACC TTC TCC ATC TAT GGC TTC FAG GCC ACC TTCAAC TAT GAA 99] 
Asn Ser Set Thr Ser I re  Phe Ata Ser I l e  Vat Thr Phe Set I l e  Tyr GLy Phe Lys Ata Thr Phe Asn Tyr Gtu ]31 
AAC TGC TTA AAC FAG GTG ATT CTG CTG CTG ACC AAT TCT TTT GAC CTT GAA CAT GGC TTT CTG ACA GCC AGC AAC 1068 
Asn Cys Leu Asn Lys VaL [Le Leu Leu Leu Thr Asn Ser Phe Asp Leu GLu Asp GLy Phe Leu Thr ALa Set Asn 356 
CTG GAG GAG GTGFAG GAC TAC CTG GCA TCT ACT TAC CCAAACFAG TAC AGT GAA GTG TTC CCA CAC ATT AGAFAC 1143 
Leu Gtu Glu Val Lys Asp Tyr Leu ALa Ser Thr Tyr Pro ASh Lys Tyr Ser Glu VaL Phe Pro His I l e  Arg A~n 381 
TGC AGC TTG GAA TCA GAG CTG AAC ACG GCT GTC CAA GGC ACA GGC CTG GCC TTC ATC GTC TAC GCT GAG GCC ATT 1218 
Cys Ser Leu Glu Ser Glu Leu Asn Thr Ata Vat Gln GLy Thr GLy Leu ALa Phe ILe VaL Tyr Ala GLu Ala I l e  406 
AAA FAC ATG GFA GTG TCC CAG CTC TGG TCA GTG CTC TAC TTC TTC ATG CTG CTG ATG CTG GGA ATG GGG AGC ATG 129] 
Lys Asn Met Glu Val Ser GLn Leu Trp Ser Val Leu Tyr Phe Phe Met Leu Leu Net Leu GLy Net GLy Set Met 431 
CTT GGA FAT ACA GCG GCC ATC CTC ACC CCT CTG ACT GAC AGC FAG GTC ATC TCC AGC TAC CTG CCC AAG GAG GCC 1368 
Leu Gty Asn Thr Ala Ala I l e  Leu Thr Pro Leu Thr Asp See Lys Vat l l e  Set Ser Tyr Leu Pro Lys Gtu Ala 456 
ATT TCA GGT CTG GTG TGC CTC ATT AAC TGT GCT GTT GGC ATG GTG TTC ACC ATG GAG GCT GGG AAC TAC TGG TTT 1443 
I le  Sen GLy Leu Val Cys Leu I re  Asn Cys Ala Val GLy Net Val Phe Thr Met Gtu Ala GLy Asn Tyr Trp Phe 481 
GAC ATA TTC FAT GAC TAT GCA GCC ACG CTG TCT CTG CTG CTC ATT GTG CTG GTG GAG ACT ATA GCT GTG TGC TAC 1518 
Asp I le  Phe ASh Asp Tyr Ala ALa Thr Leu Ser Leu Leu Leu I le  Val Leu Val Glu Thr I re  Ata Vat Cys Tyr 506 
GTG TAT GGG CTG AGG AGA TTT GAA AGT GAT CTT CGG GCC ATG ACT GGC CGG CCC CTC AAC TGG TAC TGG AAG GCC 159] 
Vat Tyr Gly Leu Arg Arg Phe Gtu Ser Asp Leu Arg Ala Met Thr Gty Arg Pro Leu Asn Trp Tyr Trp Lys Ala 511 
ATG TGG GCT TTT GTG AGC CCA CTG CTC ATC ATC GGC CTC TTT ATC TTC TAC CTG AGT GAC TAC ATC CTC ACG GGA 1608 
Met Trp Ata Phe Vat Ser Pro Leu Leu I le  I l e  Gty keu Phe I re  Phe Tyr Leu Ser Asp Tyr I l e  Leu Thr Gly 556 
ACG CTG CAG TAC CFA GCC TGG GAT GCT ACT CAG GGG CAG CTG GTG ACC AAG GAT TAC CCT CCA CAT GCA CTA GCT 1743 
Thr Leu GLn Tyr Gin ALa Trp Asp Ata Thr Gln Gly Gln Leu Vat Thr Lys Asp Tyr Pro pro His Ata Leu Ala 581 
GTC ATC GGT TTG CTG GTG GCT TCA TCT ACT ATG TGC ATC CCC CTG GTG GCC CTG GGG ACT TTC ATC AGG FAT CGC 1818 
Val I re  GLy Leu Leu Vat Ata Sen Ser Thr Met Cys I le  Pro Leu Val Ala Leu Gty Thr Phe I le  Arg Asn Arg 606 
1848 
CTC FAG AGG GGA GGC TCT TCC CCA GTG GCC TAAGAATGGACCTCCCAAAGACCGAAGTCAGCCACTCTGTTTCAC 
Leu Lys Arg GLy GLy Ser Ser Pro Vat Ata End 
616 
Fig. 1. Nucleotide sequence and deduced amino acid sequence ofthe transporter ncoded by rB21a. Nucleotides are presented in the 5' to 3' orientation 
and the coding region is numbered starting from the putative initiating methionine and ending in the termination codon. Deduced amino acid sequence 
by translation of a long open reading frame is shown using three-letter symbols; potential sites for N-linked glycosylation are designated with 
arrowheads. 
mRNA (transporter subtype) expressed only in kidney, or tis- 
sue-specific expression of an alternatively spliced transcript of 
rB21a. Quantitation of rB21a mRNA relative to 1B15, the 
mRNA encoding cyclophilin (data not shown), confirmed that 
the highest levels of rB21a mRNA were present in the brain, 
with lower levels in kidney and lung. 
To complement and extend the Northern analyses of rB21a 
mRNA, in situ hybridization studies were carried out in sec- 
tions of rat brain and kidney. As shown in Fig. 4, the mRNA 
encoding rB21a is abundant in the leptomeninges (pia/arach- 
noid) but is not observed elsewhere in the brain. In the kidney 
(Fig. 5), in agreement with Northern blot analysis, the tran- 
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Fig. 2. Alignment of deduced amino acid sequence of rB2la with related transporters. Putative ~-helical membrane spanning domains (I-XII) are 
bracketed; residues identical to those of rB21a are shaded. NTT4 represents a rat brain 'orphan' transporter [24]; v7-3 2 represents an 'orphan' 
transporter cDNA isolated from rat midbrain [23]; GAT-2 represents he rat GAT-2 GABA transporter [13]; Glycine represents the rat glycine 
transporter [8]. 
script is less abundant than in brain; its pattern of distribution 
is limited to the outer medullary layer, which contains proximal 
convoluted tubules as well as ascending and descending limbs 
of the loop of Henle. 
To ascertain which cell types in the brain express each trans- 
porter, we examined the cellular distribution of rB21a mRNA 
by Northern blot analysis of total RNA isolated from cultured 
neurons, Type 1 and O-2A/Type 2 astrocytes, leptomeningeal 
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1 .4-  
that encodes a protein with significant homology to the recently 
described family of sodium-dependent neurotransmitter trans- 
porters. The degree of amino acid identity is similar to that 
observed between neurotransmitter transporters with distinct 
substrate selectivities (i.e. glycine transporter vs. taurine trans- 
porter, ~41%), but lower than between subtypes known to trans- 
port the same substrate (i.e. GAT-2 vs. GAT-3 GABA trans- 
porters, ~67%). The transporter encoded by rB21a is predicted 
to have a large, glycosylated loop between TMs VII and VIII, 
a feature not observed in previously cloned neurotransmitter 
transporters. Together with two orphan transporters recently 
cloned from rat brain which share this feature [23,24], rB21a 
may represent a structural subfamily within the transmitter 
transporter gene family. 
We have not yet identified the endogenous ubstrate of the 
rB21a transporter. Despite significant sequence homology with 
Fig. 3. Tissue Localization of rB21a by Northern blot analysis. 
Poly(A) ÷ RNA (5 rug) from rat tissues was separated by formaldehyde/ 
agarose gel electrophoresis, blotted to nylon membranes, and hybrid- 
ized at high stringency with 32p-labeled rB21a transporter cDNA. The 
locations of RNA size markers are indicated in kilobases. The hybridiz- 
ing transcripts are ~ 3kb and ~ 2.6 kb; the autoradiogram was exposed for 
22 days. Rehybridization of the blot with 1BI5 [32] revealed that retina 
contained less mRNA than the other lanes. 
cells, and skin fibroblasts (Fig. 6). Interestingly, rB21a was 
predominantly expressed in O-2A/Type 2 astrocytes and lep- 
tomeningeal cells, with no detectable signal in neurons or skin 
fibroblasts; a very faint signal was seen in Type 1 astrocytes. 
RT-PCR amplification of rB21 a cDNA from cultured neurons, 
astrocytes, and meningeal cells confirmed a nonneuronal pat- 
tern of expression (data not shown). 
4. Discussion 
We have cloned a novel rat brain cDNA, designated rB21a, 
Table 1 
Amino acid identity of rB21a with neurotransmitter and other trans- 
porters 
Transporter Amino acid identity (percent) 
NTT4 [24] 43.6 
v7-3-2 [23] 42.6 
Betaine/GABA (BGT-1) [16] 40.5 
Creatine [22] 40.3 
Glycine [8] 40.1 
GABA (GAT-2) [13] 39.8 
Taurine [19] 39.5 
GABA (GAT-3) [13] 38.6 
GABA (GAT-1) [1] 38.3 
L-Proline [21] 36.8 
Norepinephrine [3] 36.7 
Dopamine [6,7] 36.1 
Serotonin [5] 36.4 
Sodium/glucose [33] 17.3 
Transporters epresent rat sequences except betaine (dog), norepineph- 
rine (human), and sodium/glucose (human). 
Fig. 4. Detection of rB21a transporter mRNA in the rat CNS by in situ 
hybridization. (A, B) Black and white reversal of film autoradiograms 
of coronal rat brain sections hybridized with 35S-labeled (A) antisense 
oligonucleotide (7/8 loop) and (B) sense oligonucleotide, illustrating the 
transporter's localization in the leptomeninges. (C) Liquid emulsion 
autoradiograph of the rB21a transporter mRNA in leptomeningeal 
cells covering the ventral aspect of the brain. Note the lack of hybridi- 
zation signal over smooth muscle cells of a blood vessel (asterisk). 
Bar = 100 ,um. 
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Fig. 5. Distribution of rB21a transporter mRNA in rat kidney. The 
hybridization observed with the rB21a antisense probe (A) is largely 
limited to the outer zone of the medulla (arrow); a low background is 
observed with the sense probe (B). 
the family of neurotransmitter ransporters, rB21a does not 
appear to encode a transporter for commonly known classical 
neurotransmitters. It ispossible that the substrate represents a 
class of compounds unrelated to the modulation of synaptic 
transmission; alternatively, it has been suggested that identify- 
ing the substrates of 'orphan' transporters may reveal previ- 
ously undescribed neurotransmitter systems [34]. Of the eleven 
transporters whose substrates have been characterized (see sec- 
tion 1), all are expressed in the brain and all but one (creatine 
transporter [22]) transport substrates believed to be neurotrans- 
mitters or neuromodulators. The presence of rB21 a transporter 
mRNA in brain is consistent with a neuroactive role for its 
substrate. 
Localization studies have provided clues as to the potential 
functions of rB21a. The distinct regional and cellular patterns 
of distribution of rB21 a are suggestive of a specialized function 
for the transporter, in contrast with a generalized distribution 
expected of a ubiquitous metabolite transporter. The presence 
Table 2 














Alanine (for system ASC) 
c~-(Methylamino)isobutyric acid (for system A) 
Cos-7 cells were transfected with rB21 a and tested for transport of the 
substances shown, as described in section 2. None of the potential 
substrates xhibited increased transport in the transfected cells. 
of rB21a mRNA in the lung, kidney, and leptomeninges of the 
brain suggests a role in osmoregulation. Transporters inthe pia 
could regulate the composition and volume of cerebrospinal 
fluid (CSF) and brain extracellular fluid, and could thereby 
play a role in homeostatic mechanisms to control brain swelling 
after trauma, hypoxia, seizures, or stroke. Pial transporters are 
situated to control the concentration f solutes uch as neuro- 
transmitters in the CSF; changes in levels of CSF neurotrans- 
mitters or metabolites can have profound effects on brainstem 
centers controlling functions uch as respiration and blood 
pressure. 
The detection of rB21a mRNA in cultured astrocytes sug- 
gests a wider distribution i the brain than the defined pattern 
revealed by in situ hybridization; a low level of expression per 
cell among large numbers of astrocytes may be detectable by 
Northern blot but not by in situ hybridization. Alternatively, 
astrocytes inculture may express higher levels of rB21 a mRNA 
than astrocytes in vivo; it has been suggested that cultured 
O-2A/Type 2 astrocytes represent a class of reactive glial cells 
which proliferates in response to brain injury [35]. If rB21a 
mRNA in astrocytes is expressed under pathophysiological 
conditions, it may be difficult o detect in normal brain. Inter- 
estingly, the pattern of distribution of rB21a mRNA in the 
brain closely parallels that of the fl-alanine sensitive GABA 
transporter GAT-2 [13], both in its meningeal localization [36] 
and its preferential expression i  nonneuronal cells [29]. 
U) 
G) U) 
0 - J  
9,5" 
7.5 -  
4,4 - 
2.4 -  
1 .4 -  
0 .24 - 
rB21a 
1B15 
Fig. 6. Northern blot analysis of rB21a in primary cultures from rat 
brain. Northern blots of total RNA isolated from cultured neurons, 
astrocytes, meningeal cells, and skin fibroblasts (25 ¢tg) were prepared 
as described in Fig. 3. A ~3 kb hybridizing transcript is present in 
O-2A/Type 2 astrocytes and meningeal cells but not in neurons after 
a 5 day exposure of the autoradiogram. The blot was reprobed for 1B 15 
mRNA (~ 1 kb) to confirm that equal amounts of RNA were present in 
each lane. 
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When structure/function relationships within the neurotrans- 
mitter transporter gene family are better understood, it may be 
possible to predict interactions with substrates and inhibitors 
based on amino acid sequence alone. The cloning of the cDNA 
encoding rB21 a has nevertheless provided the means to explore 
its physiological roles by pharmacological characterization, 
and by Northern and in situ mapping of its mRNA distribution. 
Further, the availability of the cDNA encoding the transporter 
will facilitate the development of antibodies and other reagents 
useful in defining the functions of the gene product in vivo. For 
example, antisense oligonucleotides which target mRNA mole- 
cules to selectively block translation of the gene product in vivo 
have been used successfully to relate the expression of a single 
gene with its functional sequelae [37,38]. The cloning of rB21a 
will allow the use of this approach to explore the functional 
consequences of blocking the expression of its mRNA without 
knowledge of its substrate. 
In summary, we have isolated a rat brain cDNA encoding 
a novel 'orphan' transporter ( B21a) whose predicted amino 
acid sequence and restricted localization within the nervous 
system suggest functional as well as structural homology with 
neurotransmitter ransporters. The highest levels of mRNA 
expression are in the leptomeninges of the brain, suggesting 
that the rB21a transporter may regulate CSF levels of its sub- 
strate. The cloning of this transporter provides the means to 
explore its physiological roles in the nervous ystem and else- 
where, and may thereby help to elucidate structure/function 
relationships within this expanding transporter gene family. 
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